Key figures

Share this page

Key figures

All key figures as of December 31. If you're looking for further financial information, please visit our financial reports page.

$1,000 except per share data  2016  2015 2014 2013 2012
Result        
Net sales  1,337,991  1,280,986  1,344,777  1,301,984  1,254,456
Operating income  98,827  179,498 161,693 57,477 165,810
Net income* 80,404 130,148 116,365 64,624 126,642
Basic earnings per share (EPS)*  0.34 0.56 0.50 0.28 0.54
Diluted earnings per share (EPS)*  0.34 0.55 0.48 0.27 0.52
Number of shares (in thousands)          
Common shares used to compute basic net income1  234,800 233,483 232,644 234,000 235,582
Common shares used to compute diluted net income2  238,993 238,647 242,806 243,400 242,020
Cash flow        
Cash flow from operations 341,602 317,497 287,965 258,957 244,880
Capital expenditures for property, plant and equipment 74,536 97,778 86,591 84,468 101,996
Free cash flow3   267,066 219,719 201,374 174,489 142,884
Balance sheet
 
Total assets  4,308,194 4,179,117 4,454,372 4,088,392 4,087,631
Cash and cash equivalents 439,180 290,011 392,667 330,303 394,037
Total long-term liabilities, including current portion 1,393,668 1,343,616 1,490,114 1,024,389 1,094,934
Total equity 2,607,096 2,568,070 2,664,876 2,731,891 2,730,979
1 Weighted average number of common shares used to compute basic net income per common share

2 Weighted average number of common shares used to compute diluted net income per common share

3 Free cash flow(cash flow from operations less capital expenditures)

 * Attributable to the owners of QIAGEN N.V.

SOCIAL SHARING